novo nordisk semaglutide products and competitors sued Eli Lilly, alleging misleading ads unfairly compare doses of Zepbound Mounjaro with Wegovy and Ozempic. Tap link in bio for full story Novo Nordisk is proactively protecting

A review describing GLP-1 drugs as promising but unproven for alcohol and substance use concludes that approved treatments should be used until safety and efficacy are demonstrated in dedicated trials

Its often a companion on a stressful workday, and it even gives energy when you are hit by fatigue

doi:10.1007/s10517-011-1332-x

The longer intake and coaching framework can reduce side effects and improve adherence

While these results must be treated with caution, the analysis shows semaglutide can be an effective tool to treat this advanced liver disease. The trials findings, published Wednesday in the New England Journal of Medicine, are almost certain to secure the drugs approval for treating MASH from the Food and Drug Administration